|

Addressing Genomic Disparities in Cancer Survivors

RECRUITINGN/ASponsored by Rutgers, The State University of New Jersey
Actively Recruiting
PhaseN/A
SponsorRutgers, The State University of New Jersey
Started2024-07-31
Est. completion2026-12
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
Locations2 sites

Summary

The goal of this observational study is to increase genetic education and genetic testing for hereditary cancer risk among Black cancer survivors. The study will: 1. Test the effectiveness of a chatbot intervention (also called relational agent, or RA) vs. enhanced usual care (EUC) on engagement in genetic education and requests for genetic testing. 2. Evaluate the impact of the chatbot vs. EUC on the process that participants use to make decisions and evaluate effects on well-being (also called psychosocial outcomes). 3. Explore the ways (methods) that influence how participants experience the intervention. 4. Explore the feasibility of incorporating a Family Sharing Portal (FSP) for participants who receive a positive test result, to facilitate family communication of these test results and genetic testing of first-degree biological relatives after they have received genetic education by the RA. The main questions this study aims to answer are which group - the chatbot (RA) group or the EUC group - is more likely to request genetic testing and which group is more likely to get (engage with) genetic education. Participants will be randomly assigned to either the chatbot (RA) group or EUC group. This means each participant has an equal chance of being placed in either group, just like flipping a coin. Each group will receive genetic education and have an opportunity to request genetic testing. Researchers will compare the chatbot (RA) group and the EUC group to see which may request more GT (genetic testing) and which group engages more with genetic education.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* 18-80 years of age
* Self-identify as Black or African American
* At least 6-months post diagnosis with any of the following cancers: breast, ovarian, uterine, prostate, colorectal, pancreatic
* Have not had genetic testing for hereditary cancer
* Have received care at one of the participating sites in the prior five years
* Meet National Comprehensive Cancer Network criteria for germline GT
* Able to read and speak in English
* Capable of providing informed consent
* Have internet access (via smartphone, tablet or computer)
* Comfortable using a computer or mobile phone independently to access information

Exclusion Criteria:

* Do not speak English
* Unable to access the Internet
* Have previously undergone germline genetic testing for hereditary cancer risk or previously had genetic counseling (GC) and declined genetic testing (GT)
* Are unable to provide informed consent

Conditions3

CancerGenetic TestingHereditary Cancer

Locations2 sites

District of Columbia

1 site
Georgetown Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia, 20007

New Jersey

1 site
Rutgers Cancer Institute
New Brunswick, New Jersey, 08901
Erin Speiser, PhD, MAerin.speiser@rutgers.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.